Pharmaceutical Care for a Patient with Trousseau Syndrome Complicated by Ovarian Cancer
10.3870/j.issn.1004-0781.2025.06.023
- VernacularTitle:1例特鲁索综合征合并卵巢癌患者的药学监护
- Author:
Bo CAO
1
;
Guangjuan XU
;
Chen CHENG
;
Yanxia YU
;
Jingjing LI
Author Information
1. 苏州大学附属苏州九院药学部,苏州 215200
- Publication Type:Journal Article
- Keywords:
Trousseau syndrome;
Ovarian cancer;
Anticoagulation;
Pharmaceutical care
- From:
Herald of Medicine
2025;44(6):977-981
- CountryChina
- Language:Chinese
-
Abstract:
Objective A safe and effective medication model was put forward through the treatment of a patient with Trousseau syndrome complicated with ovarian cancer by clinical pharmacist.Methods Clinical pharmacists participated in the treatment team to make individual treatment plan for Trousseau syndrome patients with ovarian cancer through consultation,clinical ward rounds,evidence-based medicine and discussion.Results The clinical pharmacist participated in the entire pharmaceutical care for the patients.They assisted the doctor to make individual anticoagulation and chemotherapy plan.The anticoagulation treatment was safe and effective,with no thromboembolism and hemorrhage.The chemotherapy process was smooth,with no adverse reaction occurred,and the patients condition improved,leading to discharged.Conclusion Clinical pharmacists participated in clinical evaluation of the feasibility of tumor chemotherapy plan,balanced the risk of patients with thrombosis and bleeding,formulated individualized anticoagulation treatment plan,and carried out pharmaceutical education and adverse reaction monitoring,which improved the efficacy and safety of medication in patients with ovarian cancer combined with multiple organ thromboembolism.
